Aficard 2mg Injection
Prescription Required
Product introduction
Aficard 2mg Injection is used to treat hypotension (low blood pressure) that may occur due to causes such as sepsis (infection). It helps to increase blood pressure by narrowing the blood vessels of the heart. It may be used to revive a patient with cardiac arrest.
Aficard 2mg Injection is used in the treatment of heart block, cardiac arrest, shock and heart failure
Aficard 2mg Injection is used in the treatment of heart block, cardiac arrest, shock and heart failure
Uses of Aficard Injection
- Low blood pressure
Benefits of Aficard Injection
In Low blood pressure
Aficard 2mg Injection is used to normalise decreased blood pressure (hypotension) which may occur all of a sudden during an operation, severe infection (sepsis) or due to an emergency condition (cardiac arrest). This medicine helps to bring back the blood pressure within normal range and therefore prevents any sudden fall or even serious complications that might have otherwise followed due to low blood pressure.
Side effects of Aficard Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Aficard
- Systemic hypertension (high blood pressure)
- Headache
- Restlessness
- Insomnia (difficulty in sleeping)
- Palpitations
- Tremors
How to use Aficard Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Aficard 2mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Aficard 2mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Aficard 2mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
NOT RELEVANT
Not relevant, as Aficard 2mg Injection is intended for use in hospitalised patients.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Aficard 2mg Injection in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Aficard 2mg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Aficard 2mg Injection
₹22.0/Injection
Norad 2mg Injection
Neon Laboratories Ltd
₹57/injection
159% costlier
Noradria 2mg Injection
Troikaa Pharmaceuticals Ltd
₹156.2/injection
610% costlier
Norbit Injection
Celon Laboratories Ltd
₹35/injection
59% costlier
Noralin 2mg Injection
United Biotech Pvt Ltd
₹130.72/injection
494% costlier
Nor Epineph 2mg Injection
Themis Medicare Ltd
₹192/injection
773% costlier
Quick tips
- It is given via a drip into your veins by a doctor or healthcare professional.
- During infusion your doctor will continuously monitor blood pressure, heart rate as well as site of infusion.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Fact Box
Chemical Class
Catecholamines
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Sympathomimetics agonist
Patient concerns
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 287-88.
- Teerlink JR, Sliwa K, Opie LH. Heart Failure. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 180.
- Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 139.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1001-1002.
Marketer details
Name: Aesmira Lifesciences Pvt Ltd
Address: C-3/6, Vasant Vihar, New Delhi - 110057
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹22
Inclusive of all taxes
1.0 ml in 1 vial
SOLD OUT
Notify me